Lifecore Biomedical, Inc. De (LFCR) Non-Current Deffered Revenue (2012 - 2024)
Lifecore Biomedical (LFCR) recorded quarterly Non-Current Deffered Revenue of $4.9 million in Q4 2024, up 1.86% quarter-over-quarter from $4.8 million in Q3 2024, and up 1526.67% on a YoY basis from $300000.0 in Q4 2023.
Lifecore Biomedical, Inc. De (LFCR) Non-Current Deffered Revenue (2012 - 2024) Analysis & Trends
Lifecore Biomedical's Non-Current Deffered Revenue history runs 3 years deep, the most recent figure standing at $4.9 million for Q4 2024.
- In Q4 2024, Non-Current Deffered Revenue rose 1526.67% year-over-year to $4.9 million; the TTM figure through Nov 2024 stood at $4.9 million (up 1526.67% YoY), while the FY2024 annual figure was $4.7 million, up 59.97% from the prior year.
- Non-Current Deffered Revenue was $4.9 million for Q4 2024 at Lifecore Biomedical, up from $4.8 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $4.9 million in Q4 2024 to a low of $300000.0 in Q4 2023.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 24, 2024 | 4.88 Mn |
| Aug 25, 2024 | 4.79 Mn |
| May 26, 2024 | 4.70 Mn |
| Nov 26, 2023 | 300,000.00 |
| Aug 27, 2023 | 1.69 Mn |
| May 28, 2023 | 2.94 Mn |
| Nov 25, 2012 | 246,000.00 |
| Aug 26, 2012 | 276,000.00 |
| May 27, 2012 | 162,000.00 |